Check adherence inhaler technique and possible interfering comorbidities Target exac dyspnea w additional tx Mitigate risks If advanced COPD consider palliative care and end of life support

By rray, 22 February, 2024
Exclude Patient Type Detail Header
No
Footnote
<sup>1</sup> <b>Brief cessation counseling:</b><br>
• <b>Ask</b> tobacco users about tobacco use at every visit; use office-wide identification system.<br>
• <b>Advise</b> quitting, in a clear, strong, personalized manner.<br>
• <b>Assess</b> willingness to quit, determine when (e.g., w/in next 30 days).<br>
• <b>Assist</b> w/ quit plan, including practical counseling, exploring social support, prescribing pharm tx, educational resources.<br>
• <b>Arrange</b> f/u in person or via phone, etc.
Detail Type
Text
Detail Text
If on single LABA or LAMA If eos
If on LAMA LABA If eos 100 cells L consider ICS LAMA LABA If eos
If on ICS LAMA LABA triple tx Consider removing ICS if pneumonia or other considerable ADRs If eos 300 cells L de escalation is more likely to lead to exac If FEV1
If on LABA ICS w o features of asthma If well controlled and no sx continue If further exac If eos 100 cells L treat w LABA LAMA ICS if eos
Continue short acting BD for sx rescue SAMA ipratropium MDI NEB SABA albuterol levalbuterol MDI NEB for all pts
Patient Type Detail Header (Long)
<b>Check adherence, inhaler technique, and possible interfering comorbidities. Target exac (+/- dyspnea) w/ additional tx. Mitigate risks. If advanced COPD, consider palliative care and end-of-life support.</b>